Response to the letter to the editor for the article 'clinical frailty is a risk factor of adverse outcomes in patients with esophageal cancer undergoing esophagectomy: analysis of 2011-2017 US hospitals'.
Response to the letter to the editor for the article 'clinical frailty is a risk factor of adverse outcomes in patients with esophageal cancer undergoing esophagectomy: analysis of 2011-2017 US hospitals'.
复制标题
对《临床虚弱是接受食管切除术的食管癌患者不良结果的危险因素：2011-2017 年美国医院分析》一文致编辑的回复。
DOI：
10.1093/dote/doac014
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Raffi Karagozian
中科院分区：
文献类型：
--
作者：
D. Lee;Raffi Karagozian
我们感谢您对我们发表的论文“临床虚弱是接受食管切除术的食管癌患者不良结局的风险因素：2011-2017年美国医院分析”的考虑和关注;我们希望借此机会回应您的考虑，关于第一点，我们使用以下标准选择了研究人群：（i）住院诊断为食管癌的患者和（ii）接受同一入院食管切除术的患者;实际上，我们隔离了住院诊断为这两种疾病的住院人群，以确保这两种诊断发生在同一入院时。这将排除那些患有食管癌但未进行食管切除术的患者的替代诊断，也将排除那些因非恶性原因接受食管切除术的患者。
We appreciate your consideration and concerns about our published paper ‘Clinical frailty is a risk factor of adverse outcomes in patients with esophageal cancer undergoing esophagectomy: analysis of 2011–2017 US hospitals’; we wanted to use this opportunity to respond to your considerations, With regard to the first point, we have selected the study population using the following criteria:(i) in-hospital diagnosis of esophageal cancer and (ii) those who are undergoing a same-admission esophagectomy; in effect, we isolated the admitted populations who had an in-hospital diagnosis of both conditions, to make sure that the two diagnoses occurred in the same admission. This would preclude alternative diagnoses of those with esophageal cancer but without esophagectomy and would also preclude those undergoing esophagectomy but for a nonmalignant reason.